BPC PHARMA  is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Our focus is primarily on niche therapeutic areas and complex products. We market and distribute our products in over 40 countries. We sell our FDF products in the United States, India, Europe and the rest of the world (“RoW”). We also operate in certain key geographies through our subsidiaries.

We manufacture API products which are primarily used for captive consumption in our FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, we have capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides.

We are also engaged in contract manufacturing business, whereby we undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products 

                   Active pharmaceutical ingredient[ A.PIs]

Amitriptyline hydrochloride |Cisapride monohydrate |Cinnarizine | Clopidogrel bisulphate | Cyclobenzaprine hydrochloride |Cyproheptadine hydrochloride |Dabigatran | Desloratadine |Dexlansoprazole |Diatrizoic acid Diatrizoate sodium | Diatrizoate meglumine |Dimethyl fumarate | Domperidone  | Domperidone maleate | Donepezil hydrochloride |Donepezil hydrochloride monohydrate |Ebastine |Esomeprazole magnesium trihydrate |Febuxostat |Fexofenadine hydrochloride | Flurbiprofen |Flunarizine | Itopride hydrochloride |Itraconazole | Ketorolac tromethamine | Levetiracetam |Loperamide hydrochloride |Loratadine |Losartan potassium |Mebeverine | Mirabegron | Nebivolol | Nortriptyline hydrochloride | Oxatomide anhydrous |Oxatomide monohydrate |Olmesartan medoxomil |Pantoprazole sodium sesquihydrate |Pimozide |Pimobendan |Pregabalin |Quetiapihe hemifumarate |Rivaroxaban | Rupatadine fumarate |Telmisartan |Tamsulosin hydrochloride

Note :
1. ALL THE MATERIAL ARE PROVIDED ACCORDING TO BP/USP/EP.
2. NONE OF THE PRODUCTS WILL BE SUPPLIED TO COUNTRIES IN WHICH THIS COULD BE IN CONFLICT WITH THE EXISTING PATENTS. HOWEVER THE FINAL RESPONSIBILITY LIES WITH THE BUYER